Here are the biggest calls on Wall Street on Thursday: Goldman Sachs reiterates Nvidia as buy Goldman says it's sticking with Nvidia ahead of earnings in late February. "We expect investors to focus on (1) directional commentary on visibility into 2027; (2) non-traditional customer demand trends; (3) competitive dynamics; (3) China business trends." Benchmark initiates Cava as buy Benchmark says the Mediterranean restaurant chain is a category leader. "We are initiating coverage of the CAVA Group ( CAVA) with a Buy rating and an $80 price target (22% upside), reflecting the scale leadership position that CAVA enjoys in the rapidly emerging Mediterranean category." BMO Capital upgrades Brookfield Asset Management to outperform from market perform BMO says it sees an "attractive risk/reward." " BAM's prospects for mid-teens distributable earnings growth are intact underpinned by continued fundraising momentum across strategies as well as fee rate and margin resiliency." Jefferies reiterates Broadcom as a top pick Jefferies says investors should buy any weakness in Broadcom. "Strong history of M & A, which we believe should see strong synergies and provide an even larger value proposition to customers. Expect a continued M & A path of software deals every few years." Stifel downgrades Microsoft to hold from buy The firm lowered its price target to $392 from $540 and says it's taking a breather. "We downgrade MSFT to Hold as we believe Street FY/CY27 revenue/EPS expectations are to optimistic." Read more. Baird upgrades Jack Henry to outperform from neutral Baird says it sees strong upside potential for Jack Henry. "We are upgrading to Outperform. FQ2 beat nicely on revenue and especially margins, and momentum remains strong. We are upgrading given ongoing strong execution/share gains, with potential for increased share gains as Fiserv consolidates platforms, along with improving market backdrop" DA Davidson upgrades Varonis Systems to buy from neutral DA upgraded the software company after two years on the sideline. "VRNS has been beaten like a piñata, -63% from the 52-week high in Oct'25. We have been on the sidelines for two years due to our concerns around ARR [annual recurring revenue] growth durability post SaaS conversions, and ARR growth has now decelerated due to increasing on-premise churn." Bank of America reiterates Alphabet as buy Bank of America says the AI thesis is alive and well following earnings. "We see Alphabet as well positioned long term with leading AI technology to apply to search, YouTube and Cloud businesses. Alphabet should also benefit from increasing mobile usage, video usage, Google Play activity, and connected device activity." Read more. Seaport upgrades FuboTV to buy from neutral Seaport says it now has increasing visibility. "FUBO shares just posted their first quarter post-merger of Disney's Hulu Live (just the programming sourcing part of the business) with FuboTV. With the new business model shift; a level-setting of estimates now that there is more clarity that proxy projections, including synergies early on; no guidance yet;" Cantor Fitzgerald upgrades DigitalOcean to overweight from neutral Cantor says it sees multiple expansion ahead. "We are raising our rating to OW (from Neutral) and our 12-month PT to $68 (from $47) on DOCN shares representing ~6x our C27 updated revenue targets, which are now above the Street consensus." Evercore ISI upgrades Bread Financial to outperform from in line The firm says shares are compelling at current levels. "We are upgrading BFH to Outperform from In Line as we expect Bread's improving earnings trends, inflecting growth trajectory, well-managed credit risk, and solid capital return to present upside to the stock's discount valuation." UBS upgrades Ermenegildo Zegna to buy from Neutral UBS says shares of the luxury retailer have more room to run. "We have been fundamentally constructive on ZGN's growth prospects, underpinned by the consistently strong +DD% momentum of western consumers for the core Zegna brand (~60% of group sales), alongside tailored clienteling strategy and smart merchandising initiatives that continue to resonate with high-end consumers across generations." Jefferies upgrades Celanese to buy from hold Jefferies says it's time to buy the dip in the chemicals company. "Given significant operating leverage to a demand cycle, amplified by financial leverage, we upgrade Celanese to Buy from Hold." Citizens upgrades Uber to market outperform from market perform Citizens upgraded the stock following earnings. "We are upgrading shares of Uber to Market Outperform from Market Perform after 4Q25 results." Deutsche Bank upgrades Adient to buy from hold Deutsche said in its upgrade of Adient that it sees a "compelling turnaround story" for the auto seating company. "Following strong F1Q results and a broadly better outlook, we upgrade the stock from Hold to Buy, seeing a compelling turnaround story." Wolfe upgrades Zoom to outperform from peer perform Wolfe called the stock a " low growth cash cow." "We are upgrading shares of ZM to Outperform with a $115 PT." Wells Fargo downgrades Fox to equal weight from overweight Wells says the upside is already priced in for Fox shares. "We raise ests & our PT moves to $75 ($80 prior). We think a lot of the upside is now understood w/ the catalyst path ahead more mixed. If M & A heats up we could get more bullish, but at 10.8x CY26 EV/EBITDA a lot is in the price. Move to Equal Weight." Citizens reiterates Oracle as market outperform Citizens lowered its price target on the stock to $285 per share from $342. "We maintain our Market Outperform rating though reduce our price target to $285 from $342 on Oracle Corporation after the company's debt financing deal was priced on February 2, raising $30B in total with two debt instruments, including: 1) a $5B mandatory convertible preferred offering; and 2) $25B in senior notes across multiple maturities..." Bank of America downgrades Qualcomm to neutral from buy Bank of America downgraded the stock following earnings on "lowered handset expectations." "We are downgrading Qualcomm from Buy to Neutral and lowering our PO from $215 to $155, based on 13.5x FY27E P/E vs 17x prior, on a combination of cyclical and structural weakness in handsets." Bank of America initiates Wave Life Sciences as buy Bank of America says shares of the biotech company have plenty of upside. "We are initiating coverage of Wave Life Sciences (WVE), a clinical-stage RNA medicines company developing drugs for obesity and genetic disorders, with a Buy rating and $38 PO."
